COMMUNIQUÉS West-GlobeNewswire

-
Immunocore announces upcoming presentation and posters at ASCO 2024
24/04/2024 -
Merus Announces Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
24/04/2024 -
ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting
24/04/2024 -
CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024
24/04/2024 -
Clearday introduces digital assistants in residential communities
24/04/2024 -
Sometimes Legends Come in Small Packages
24/04/2024 -
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
24/04/2024 -
Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary
24/04/2024 -
Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center
24/04/2024 -
Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers
24/04/2024 -
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
24/04/2024 -
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG
24/04/2024 -
Sharecare awarded three-year NCQA Accreditation for Case Management
24/04/2024 -
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
24/04/2024 -
Verana Health Announces Launch of Qdata® Thyroid Eye Disease
24/04/2024 -
T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024
24/04/2024 -
Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
24/04/2024 -
Canadians Come Together to Make Positive Impact During Multiple Sclerosis Awareness Month This May
24/04/2024 -
Doheny Eye Institute Announces Upcoming Presentations at ARVO 2024 Annual Meeting
24/04/2024
Pages